Grant name: Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
Funding organization: National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Total funding amount: Direct costs may not exceed $500,000 without prior approval
Duration: Maximum project period is five years
Primary objective: To advance research on alcohol treatment and recovery, focusing on AUD
Funding source: Federal government
Significance: Addresses a major public health issue affecting millions
Grant frequency: Recurring
Higher Education Institutions
Public/State Controlled Institutions of Higher Education
Private Institutions of Higher Education
Nonprofits (with and without 501(c)(3) status)
For-Profit Organizations (including Small Businesses)
Local, State, County, City Governments
Indian/Native American Tribal Governments (both recognized and non-recognized)
Federal Government Agencies
Foreign Organizations
Must have an eRA Commons account for Principal Investigators
Registration in System for Award Management (SAM) required
Medications development for AUD
Behavioral therapies and mechanisms of behavioral change
Recovery research and translational research
Innovative methods and technologies for AUD treatment
Individuals with alcohol use disorder
Special emphasis on underserved populations
Research must be conducted in humans
Clinical trial design must be robust and scientifically sound
Direct costs may not exceed $500,000 without prior approval
No cost-sharing required
Open Date: January 05, 2025
Application Due Dates: February 05, 2025; June 05, 2025; October 05, 2025; February 05, 2026; June 05, 2026
Must comply with NIH Grants Policy Statement
Data Management and Sharing Plan required
Applications must be submitted electronically via Grants.gov
Follow specific instructions in the Application Guide